Skip to main content

Table 5 Direct medical costs of genital herpes among claims database enrollees and extrapolated US estimates

From: The estimated economic burden of genital herpes in the United States. An analysis using two costing approaches

Type of patient Mean cost ($) SD ($) Median cost ($) Mean total US costs
     (in Mio $)
Incident GH 235 418 86 30.8
Prevalent GH 166 393 43 89.8
Active GH 355 536 191 21.8
Recurrent GH 499 707 359 101.6
  1. Note: Costs are expressed in 1996 US$.